Havshield 250IU Injection
Havshield 250IU Injection is an inactivated hepatitis A vaccine used to protect individuals against hepatitis A virus (HAV), a liver infection spread through contaminated food or water. Administered in two doses 6–12 months apart, it provides long-term immunity in children (12 months and older) and unvaccinated adults.
Contact us for sales assistance from our Biomedical Engineer.
Features:
-
Inactivated Vaccine: Contains killed hepatitis A virus, safe for both children and adults.
-
Two-Dose Protection: Administered in a two-shot schedule for extended immunity.
-
Pediatric & Adult Use: Approved for individuals 12 months of age and older.
-
Clinically Proven Safety: Low incidence of adverse effects, with mild and temporary symptoms.
-
Convenient Administration: Intramuscular injection, typically in the deltoid region.
| Technical Specification |
|
|---|
- 1 X 0.5ml
-
Long-Term Protection: Dual dose ensures prolonged immunity against HAV.
-
Safe for Children & Adults: Can be used starting from 12 months of age.
-
Prevents Liver Complications: Reduces risk of severe hepatitis A outcomes like liver inflammation or failure.
-
Helps Prevent Outbreaks: Contributes to herd immunity in high-risk areas.
-
Minimal Side Effects: Mild and self-limiting reactions like soreness and fatigue.
